BRCA2 and breast carcinoma: In this regard, several antigens, e.g., BRCA1, BRCA2, BR 27.29, CA 15-3, CA 27.29, CEA, c-myc, HER-2/neu, MUC-1, or p53 have been reported for monitoring breast cancer progression [24].